Stock Information
Neurogene Inc (NGNE)
Ticker Symbol: NGNE
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $320.48 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -3.1555
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -25.27%
Latest News
-
Canaccord Genuity Maintains Buy on Neurogene, Lowers Price Target to $180
Mon, Apr 6, 2026 11:13 AM
Key Financials
Financial data not available